sanofi

U.S. FTC requires divestitures in $13.53 billion Boehringer-Sanofi deal

German pharmaceutical company Boehringer Ingelheim agreed to divest five types of animal health products to settle charges that a proposed asset swap with Sanofi would harm competition, the U.S. Federal Trade Commission…

See original here:
U.S. FTC requires divestitures in $13.53 billion Boehringer-Sanofi deal

sanofi

Mitsubishi Motors brings in new R&D chief, restates results after scandal

Mitsubishi Motors Corp said a Nissan Motor Co executive would become its head of research and development, part of a management overhaul in the wake of a mileage cheating scandal that also prompted it to restate earnings. Nissan is preparing to take a controlling one-third stake in Mitsubishi, which is reeling from its third scandal in two decades. Mitsubishi has seen over $3 billion wiped off its market value after admitting last month it overstated the …

Read the original post: 
Mitsubishi Motors brings in new R&D chief, restates results after scandal

sanofi

Exclusive: U.S. queries AB InBev on distribution incentives amid merger probe

By Diane Bartz WASHINGTON (Reuters) – U.S. antitrust officials are investigating Anheuser-Busch InBev over its new incentives that encourage independent distributors to sell more of its own beer brands at the expense of competing craft brews, two people with knowledge of the matter said. Budweiser owner AB InBev has 45.8 percent of the U.S. beer market but has seen sales…

See original here: 
Exclusive: U.S. queries AB InBev on distribution incentives amid merger probe

sanofi

EU regulators clear $100 billion-plus AB InBev, SABMiller deal

The world's largest brewer Anheuser-Busch InBev gained EU antitrust approval on Tuesday for its $100 billion-plus acquisition of SABMiller on condition it sell almost the whole of SABMiller's beer business in Europe. Reuters was the first to report that AB InBev's concessions to sell substantial assets would secure the EU green light for one of the largest corporate takeovers ever. AB InBev has already agreed to sell SABMiller&#…

View original post here:
EU regulators clear $100 billion-plus AB InBev, SABMiller deal

sanofi

Exclusive: Sanofi to unveil challenge to Medivation’s board – sources

France's Sanofi SA is preparing to name candidates it will put forward to replace the entire board of U.S. cancer drug company Medivation Inc as early as Wednesday, according to people familiar with the matter. Sanofi has threatened to oust the board after Medivation rejected its unsolicited $9.3 billion acquisition offer late last month, taking advantage of a so-called 'written consent' rule that gives Medivation shareholders the…

Excerpt from:
Exclusive: Sanofi to unveil challenge to Medivation’s board – sources